Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-04-30 @ 8:09 AM
Study NCT ID:
NCT00154102
Status:
COMPLETED
Last Update Posted:
2017-01-30
First Post:
2005-09-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer | View |